Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 3:57 AM
Ignite Modification Date:
2025-12-25 @ 3:57 AM
NCT ID:
NCT02087202
Brief Summary:
NMDA receptor is administered and postoperative remote hyperalgesia is investigated.
Detailed Description:
NMDA receptor is adminstered and postoperative tertiary hyperalgesia is investigated.
QST and pain measures for remote hyperalgesia are compared between control and magnesium or ketamine group.
Study:
NCT02087202
Study Brief:
Protocol Section:
NCT02087202